Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan.

BMC Ophthalmology
Kenji KashiwagiPoh Sin Yap

Abstract

Poor persistence with glaucoma therapy can lead to disease progression and subsequent blindness. Persistence with second-line glaucoma combination treatment in a Japanese real-world setting and whether it differed from fixed and unfixed combination drugs was investigated. This was a retrospective, non-interventional, cohort study using data from a Japanese medical claims database. Patients with glaucoma aged ≥20 years with a first drug claim for glaucoma treatment between 01 July 2005 and 30 October 2014 and with data for > 6 months before and after this first prescription were included. The primary endpoint was duration of drug persistence among glaucoma patients with and without the use of fixed combination drugs in the year following initiation of second-line combination treatment. Of 1403 patients included in the analysis, 364 (25.94%) received fixed combination drugs and 1039 (74.06%) received unfixed combination drugs as second-line treatment. Baseline characteristics were generally comparable between the groups. A total of 39.01% of patients on fixed combination drugs, compared with 41.67% of patients on unfixed combination drugs, persisted on their glaucoma drugs 12 months post second-index date. Median persistence dura...Continue Reading

References

Jan 25, 2005·Drugs & Aging·Robert E Marquis, Jess T Whitson
Aug 10, 2007·American Journal of Ophthalmology·Alan L RobinTania S Marcic
Nov 27, 2007·Expert Opinion on Pharmacotherapy·Jess T Whitson
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Samy Suissa, Edeltraut Garbe
Mar 25, 2008·Therapeutics and Clinical Risk Management·Robert J Noecker
Sep 8, 2009·Current Medical Research and Opinion·Eve J HigginbothamAngela Guckian
Aug 4, 2010·American Journal of Ophthalmology·Vicky H LuChristine Y Lu
Jan 12, 2011·Archives of Ophthalmology·Desmond T L QuekTin Aung
Aug 30, 2011·American Journal of Ophthalmology·Simon E SkalickyPeter McCluskey
Jan 11, 2014·Japanese Journal of Ophthalmology·Kenji Kashiwagi, Toshie Furuya
Jul 24, 2014·Journal of Glaucoma·Victoria C LeungWilliam G Macrae
Apr 29, 2015·Ophthalmology·Paula Anne Newman-CaseyPaul P Lee
Dec 23, 2015·Journal of Comparative Effectiveness Research·Anne L ColemanUNKNOWN RiGOR Study Group
Feb 24, 2016·Medical Journal, Armed Forces India·J K S Parihar
Mar 9, 2017·The British Journal of Ophthalmology·Chan Yun KimYoung-Joo Kim
May 26, 2017·Neurodegenerative Disease Management·Gurjeet JutleyM Francesca Cordeiro

❮ Previous
Next ❯

Citations

Aug 10, 2021·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ai KidoKoji Kawakami

❮ Previous
Next ❯

Software Mentioned

SAS Studio

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.